Writing Intervention With Adolescents and Young Adults With Cancer
ChronCan (Chronicling Cancer): Piloting a Novel Writing Intervention With Adolescents and Young Adults With Cancer
2 other identifiers
interventional
26
1 country
1
Brief Summary
Young people with cancer have difficult experiences and writing exercises may help improve their well-being. However, very few studies have examined how a creative writing activity might be useful for young people with cancer. In this pilot study, researchers at St. Jude Children's Research Hospital hope to explore whether teenagers and young adults with cancer want to participate in a writing exercise and whether they find it to be valuable. Primary Objective To assess the feasibility and acceptability of a writing-based narrative medicine intervention for adolescent and young adult patients with cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2023
CompletedStudy Start
First participant enrolled
August 2, 2023
CompletedFirst Posted
Study publicly available on registry
August 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
ExpectedMarch 30, 2026
March 1, 2026
10 months
July 27, 2023
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of touchpoints that participants have with the narrative medicine expert/guide
To determine intervention feasibility, the number of touchpoints that participants have with the narrative medicine expert/guide will be tracked
During the narrative exercise, up to 2 months after enrollment
Number of participants who complete the writing exercise
To determine intervention feasibility, the number of participants who complete the writing exercise will be tracked
During the narrative exercise, up to 2 months after enrollment
Intervention acceptability
Comparison of acceptability between participants who did/did not participate in the optional check-ins. Analysis of de-identified semi-structured interviews will be done. Interviews will be recorded, transcribed, de-identified, and analyzed using content analysis, an inductive approach that includes memo-writing, codebook development, coding, reconciliation, and synthesis to identify emerging patterns and themes.
Post-intervention interview will occur after the narrative exercise is completed at around 2 months after enrollment, +/- 1 month
Study Arms (1)
Participants
EXPERIMENTALAdolescents and young adults (AYA) patients aged 15-25 years currently receiving cancer-directed therapy at St. Jude Children's Research Hospital
Interventions
Participants will be asked to write about their experiences with cancer, guided by several specific open-ended writing prompts to spark ideas.
Following completion of the writing exercise, participants will reflect on their experiences with the writing intervention in a semi-structured private interview with a member of the research team.
Eligibility Criteria
You may qualify if:
- Aged 15-25
- Currently receiving cancer-directed therapy
- Active patient at St. Jude Children's Research Hospital
- Parent of a ChronCan participant who has passed away
You may not qualify if:
- If the parents have not responded or not interviewed till July 31, 2027.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erica Kaye, MD
St. Jude Children's Research Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2023
First Posted
August 3, 2023
Study Start
August 2, 2023
Primary Completion
May 17, 2024
Study Completion (Estimated)
July 1, 2027
Last Updated
March 30, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be made available at the time of article publication.
- Access Criteria
- Data will be provided to researchers following a formal request with the following information: full name of requestor, affiliation, data set requested, and timing of when data is needed. As an informational point, the lead statistician and study principal investigator will be informed that primary results datasets have been requested.
Individual participant de-identified datasets containing the variables analyzed in the published article will be made available (related to the study primary or secondary objectives contained in the publication). Supporting documents such as the protocol, statistical analyses plan, and informed consent are available through the CTG website for the specific study. Data used to generate the published article will be made available at the time of article publication. Investigators who seek access to individual level de-identified data will contact the computing team in the Department of Biostatistics (ClinTrialDataRequest@stjude.org) who will respond to the data request.